Immunovia Publ (Sweden) Analysis
| IMMNOV Stock | SEK 0.63 0.01 1.61% |
Immunovia publ AB is overvalued with Real Value of 0.6 and Hype Value of 0.63. The main objective of Immunovia Publ stock analysis is to determine its intrinsic value, which is an estimate of what Immunovia publ AB is worth, separate from its market price. There are two main types of Immunovia Publ's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Immunovia Publ's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Immunovia Publ's stock to identify patterns and trends that may indicate its future price movements.
The Immunovia Publ stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Immunovia Publ's ongoing operational relationships across important fundamental and technical indicators.
Immunovia |
Immunovia Stock Analysis Notes
About 36.0% of the company shares are held by company insiders. The book value of Immunovia Publ was currently reported as 13.09. The company recorded a loss per share of 7.81. Immunovia publ AB had not issued any dividends in recent years. Immunovia AB , a molecular diagnostics company, develops and commercializes diagnostic tools for cancer and autoimmune diseases in Sweden and internationally. Immunovia AB was founded in 2007 and is headquartered in Lund, Sweden. Immunovia operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 46 people. To learn more about Immunovia publ AB call Philipp Mathieu at 46 4 62 75 60 00 or check out https://www.immunovia.com.Immunovia publ AB Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Immunovia Publ's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Immunovia publ AB or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Immunovia publ AB generated a negative expected return over the last 90 days | |
| Immunovia publ AB has high historical volatility and very poor performance | |
| Immunovia publ AB has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 844 K. Net Loss for the year was (166.63 M) with profit before overhead, payroll, taxes, and interest of 15.81 M. | |
| Immunovia publ AB has accumulated about 359.85 M in cash with (152.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 18.42, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 36.0% of the company shares are held by company insiders |
Immunovia Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 479.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Immunovia Publ's market, we take the total number of its shares issued and multiply it by Immunovia Publ's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of November, Immunovia Publ retains the Standard Deviation of 9.38, risk adjusted performance of (0.01), and Market Risk Adjusted Performance of 0.8954. Immunovia Publ technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Immunovia publ AB Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Immunovia Publ middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Immunovia publ AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Immunovia Publ Outstanding Bonds
Immunovia Publ issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Immunovia publ AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Immunovia bonds can be classified according to their maturity, which is the date when Immunovia publ AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Immunovia Publ Predictive Daily Indicators
Immunovia Publ intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Immunovia Publ stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 70635.8 | |||
| Daily Balance Of Power | 0.3333 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 0.63 | |||
| Day Typical Price | 0.63 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.01 |
Immunovia Publ Forecast Models
Immunovia Publ's time-series forecasting models are one of many Immunovia Publ's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immunovia Publ's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Immunovia Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Immunovia Publ prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Immunovia shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Immunovia Publ. By using and applying Immunovia Stock analysis, traders can create a robust methodology for identifying Immunovia entry and exit points for their positions.
Immunovia AB , a molecular diagnostics company, develops and commercializes diagnostic tools for cancer and autoimmune diseases in Sweden and internationally. Immunovia AB was founded in 2007 and is headquartered in Lund, Sweden. Immunovia operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 46 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Immunovia Publ to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Complementary Tools for Immunovia Stock analysis
When running Immunovia Publ's price analysis, check to measure Immunovia Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovia Publ is operating at the current time. Most of Immunovia Publ's value examination focuses on studying past and present price action to predict the probability of Immunovia Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovia Publ's price. Additionally, you may evaluate how the addition of Immunovia Publ to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |